Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rifaximin (550mg)
Therapeutic Category
Antibacterials, Antibiotic, Antidiarrheal, Gastroenterology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹467/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rifaboly 550 Tablet is a potent antibiotic formulated to treat various gastrointestinal infections caused by susceptible bacteria. It contains 550 mg of rifaximin, a broad-spectrum antimicrobial agent known for its efficacy in targeting specific strains of bacteria in the gut. Unlike many traditional antibiotics, rifaximin is minimally absorbed into the bloodstream, allowing it to act locally in the intestines. This makes it particularly effective for conditions such as traveler's diarrhea, non-invasive strains of Escherichia coli, and hepatic encephalopathy. The unique properties of rifaximin help in restoring the natural balance of gut flora while effectively eliminating harmful pathogens.
The mechanism of action of rifaximin involves inhibiting bacterial RNA synthesis by binding to the beta-subunit of bacterial RNA polymerase. This disruption prevents the growth and reproduction of bacteria, facilitating a quicker recovery from infection. Because of its localized action, rifaximin is often preferred for patients with liver disease and those prone to recurrent gastrointestinal infections, offering a targeted approach with minimal systemic side effects.
Common side effects may include nausea, headache, dizziness, abdominal pain, and flatulence. Rare but serious effects can occur; consult a physician if severe reactions develop.
Rifaboly 550 Tablet is indicated for the treatment of traveler's diarrhea caused by non-invasive strains of E. coli, hepatic encephalopathy, and other gastrointestinal infections as directed by a healthcare professional.
Consult your healthcare provider before using Rifaboly 550 Tablet, especially if you have a history of liver disease or are taking other medications. Avoid using this medication for viral infections such as the common cold or flu. Rifaboly 550 Tablet offers a reliable treatment option for specific gastrointestinal infections, enabling patients to recover effectively while maintaining gut health. Always follow medical advice for dosage and duration of therapy to ensure the best outcomes.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Rifaximin (400mg)
Composition : Amoxycillin (875mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (750mg) + Pantoprazole (40mg) + Clarithromycin (500mg)
Composition : Fluconazole (150mg) + Azithromycin (1gm) + Secnidazole (1gm) Tablet
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg) + Lactobacillus
Composition : Amoxycillin (500mg) + Clavulanic Acid (125mg)
Composition : Amoxycillin (250mg) + Clavulanic Acid (125mg)
Composition : Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Composition : Azithromycin (250mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rifaximin 550mg Tablet has strong demand in the gastroenterology, hepatology, and chronic gut disorder segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced GI and liver-related therapies.
Medical distributors and agencies can benefit from consistent demand for intestinal and hepatic disorder management under specialist supervision. Rifaximin 550mg is a gut-selective antibiotic with minimal systemic absorption Commonly prescribed for irritable bowel syndrome with diarrhea (IBS-D), traveler’s diarrhea, small intestinal bacterial overgrowth (SIBO), and hepatic encephalopathy (to reduce ammonia-producing gut bacteria) Helps improve gut microbial balance while reducing harmful bacteria in the intestine Widely used by gastroenterologists and hepatologists Considered a specialist-driven chronic therapy product with strong repeat prescription potential This strengthens a high-value gastroenterology and hepatology portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Rifaximin 550mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from specialist gastroenterology demand, chronic therapy usage, strong prescription retention, and premium-margin positioning, along with reliable supply chain support.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional pharmaceutical support and a dependable supply chain for long-term business growth.